Diabetes patients have long been in search of less painful1 insulin injection.
Terumo has made this possible with the advanced NANOPASS 34 - the world’s thinnest double tapered pen needle2 with a diameter of only 34G.
NANOPASS 34G reduces pain through several advanced technologies.
NANOPASS 34 is 22% thinner than 32G.
The unique asymmetric edge3 of NANOPASS 34 cuts the skin instead of puncturing it.
This decreases the resistance while penetrating the skin. Another step towards less painful1 insulin injection.
The patented slim double tapered needle shape3 reduces the insulin injection force significantly.
Although the needle end is 34G, NANOPASS 34 provides less injection force than a conventional 32G pen needle.
NANOPASS 34 combines less painful1 injection with easy handling.
Nanopass®34G is not sold in North America.
The device has no components made of natural rubber latex.
For detailed list of compatible devices, see NANOPASS pen needle box
Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.
1 Asakura T., Seino H., 2013, Jpn J Med Pharm Sci 69(1):137-146. & Asakura T., 2013, Jpn J Med Pharm Sci 69(1):147-155
2 Based on research by Terumo Corporation in May 2017
3 Patented Technology